Climb Bio Inc (CLYM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,897 | -35,119 | -45,244 | -47,480 | -20,668 |
| Depreciation Amortization | -757 | -2,331 | -177 | 370 | N/A |
| Accounts payable and accrued liabilities | -963 | -686 | -653 | 318 | -167 |
| Other Working Capital | 1,698 | 3,764 | 210 | -4,172 | -2,936 |
| Other Operating Activity | 58,357 | 13,773 | 8,495 | 14,892 | 9,673 |
| Operating Cash Flow | $-15,562 | $-20,599 | $-37,369 | $-36,072 | $-14,098 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -111,447 | 68,981 | 34,440 | -114,970 | N/A |
| Other Investing Activity | -9,645 | 0 | 0 | 0 | 8,078 |
| Investing Cash Flow | $-121,092 | $68,981 | $34,440 | $-114,970 | $8,078 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 130,729 | 841 | N/A | 83,293 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 93,939 | 4,925 |
| Financing Cash Flow | $130,729 | $841 | $N/A | $177,232 | $4,925 |
| Exchange Rate Effect | 42 | 304 | -408 | 245 | 359 |
| Beginning Cash Position | 93,112 | 43,585 | 46,922 | 20,487 | 21,223 |
| End Cash Position | 87,229 | 93,112 | 43,585 | 46,922 | 20,487 |
| Net Cash Flow | $-5,883 | $49,527 | $-3,337 | $26,435 | $-736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,562 | -20,599 | -37,369 | -36,072 | -14,098 |
| Free Cash Flow | -15,562 | -20,599 | -37,369 | -36,072 | -14,098 |